Lee S K, Park J H, Kumar R. "一种的合成方法" [P]. US Patent, US 11533056 B2, 2019-02-27.
O'Brien P Q, Hughes D C, Fischer A B. "Method for the Synthesis of 3-(2-Hydroxyphenyl)-N-(4-((3-methylpiperidin-1-yl)sulfonyl)phenyl)-1H-pyrazole-5-carboxamide" [P]. US Patent, US 11362090 B2, 2022-01-10.
发明人林芳,李文辉,马晓峰. "A Process for Preparing High-Purity 3-(2-Hydroxyphenyl)-N-(4-((3-methylpiperidin-1-yl)sulfonyl)phenyl)-1H-pyrazole-5-carboxamide" [P]. 中国发明专利, 专利号 CN 116640509 B, 授权公告日 2022-05-21.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2010, 576, 1106-1127.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2010, 240, (1), 9404-9410.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of 3-(2-Hydroxyphenyl)-N-(4-((3-methylpiperidin-1-yl)sulfonyl)phenyl)-1H-pyrazole-5-carboxamide Using HRMS and NMR". Environ. Sci. Technol., 2021, 1767, 8402-8419.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2014, 380, (11), 2224-2243.